Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.
ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction.
Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange.
SPEAKERS
Deborah (Deb) Pasko, BSPharm, PharmD, MHA is a Data Solutions Architect and Program Director at Parexel International. Dr. Pasko received her BSPharm degree from Ohio Northern University, PharmD degree from Idaho State University, and her Masters of Health Administration degree from Walden University. She completed a fellowship in Nephrology and Critical Care at the University of Michigan – College of Pharmacy in Ann Arbor, MI.
Rita K. Jew, PharmD, MBA, BCPPS, FASHP is President at the Institute for Safe Medication Practice (ISMP), Plymouth Meeting, Pennsylvania. Prior to ISMP, Dr. Jew held various leadership positions including Director of Pharmacy at UCSF Health, Executive Director of Pharmacy & Clinical Nutrition Services at CHOC Children’s and Clinical Manager at Children’s Hospital of Philadelphia. Dr. Jew received her PharmD from University of California at San Francisco, completed an ASHP-Accredited Residency in Clinical Pharmacy at Thomas Jefferson University Hospital and received her MBA from the Wharton School, University of Pennsylvania. She is a Board-Certified Pediatric Pharmacy Specialist (BCPPS).
Mary Ann Kliethermes, PharmD, FASHP received a BS in pharmacy from the University of Michigan (1977) and Doctor of Pharmacy from the Philadelphia College of Pharmacy and Science (1981). Her 45 year clinical practice includes hospital, home infusion, ambulatory practice and academia. Currently she is Director of Medication Safety and Quality at ASHP. Her expertise is pharmacist reimbursement, medication optimization, safety and quality, and new healthcare models and payment systems.
Relevant Financial Relationship Disclosures
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.
More in this series
Standardize 4 Safety: How Did It Start and Where Is It Going?
Standardize 4 Safety: Taking Aim at Strategies for Adoption
Provided by ASHP
Sponsored by Baxter Healthcare Corporation